Sep 4, 2018 8:31 am EDT EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies
Sep 4, 2018 8:30 am EDT EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis
Aug 29, 2018 8:30 am EDT EyeGate Pharmaceuticals Announces Participation at the H.C. Wainwright 20th Annual Global Investment Conference
Aug 3, 2018 8:30 am EDT EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Jul 24, 2018 8:30 am EDT EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
Jun 22, 2018 8:30 am EDT EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
May 30, 2018 8:30 am EDT EyeGate Files Supplement to Investigational Device Exemption to Commence Study in Punctate Epitheliopathy using the EyeGate Ocular Bandage Gel
May 22, 2018 8:30 am EDT EyeGate Addresses Majority of FDA’s Action Items with Submission of Investigational Device Exemption Amendment for Ocular Bandage Gel